Expected Earnings for Tuesday

22nd Century Group Inc (XXII) is expected to report for 2Q.

AEterna Zentaris Inc (AEZS,AEZS.T) is expected to report for 2Q.

Adicet Bio Inc (ACET) is expected to report $-0.35 for 2Q.

Aerovate Therapeutics Inc (AVTE) is expected to report $-0.82 for 2Q.

Aimia is expected to report for 2Q.

Air Industries Group (AIRI) is expected to report for 2Q.

Broadwind Inc (BWEN) is expected to report $0.01 for 2Q.

Chimerix (CMRX) is expected to report $-0.21 for 2Q.

Cipher Mining Inc (CIFR) is expected to report $-0.04 for 2Q.

Drive Shack Inc (DSHK) is expected to report $-0.06 for 1Q.

Entree Resources Ltd (EGI,ETG.T) is expected to report for 2Q.

Fennec Pharmaceuticals Inc (FENC,FRX.T) is expected to report $-0.03 for 2Q.

Hudbay Minerals Inc (HBM,HBM.T) is expected to report $0.09 for 2Q.

Humacyte Inc (HUMA) is expected to report $-0.24 for 2Q.

Hut 8 Corp (HUT.T) is expected to report for 2Q.

Hyzon Motors Inc (HYZN) is expected to report $-0.15 for 2Q.

Inozyme Pharma Inc (INZY) is expected to report $-0.43 for 2Q.

KP Tissue is expected to report for 2Q.

Lifeway Foods Inc (LWAY) is expected to report $0.20 for 2Q.

Local Bounti Corp (LOCL) is expected to report $-3.19 for 2Q.

Marinus Pharmaceuticals Inc (MRNS) is expected to report $-0.59 for 2Q.

Melco Resorts & Entertainment Ltd (MLCO) is expected to report $0.09 for 2Q.

Mersana Therapeutics Inc (MRSN) is expected to report $-0.18 for 2Q.

Mind Medicine (MindMed) Inc (MNMD) is expected to report $-0.31 for 2Q.

OrganiGram Holdings Inc (OGI,OGI.T) is expected to report for 3Q.

Oxford Square Capital Corp (OXSQ) is expected to report $0.70 for 2Q.

PDS Biotechnology Corp (PDSB) is expected to report $-0.40 for 2Q.

Praxis Precision Medicines Inc (PRAX) is expected to report $-2.27 for 2Q.

Quantum Corp (QMCO) is expected to report $-0.09 for 1Q.

SANUWAVE Health (SNWV) is expected to report for 2Q.

Seres Therapeutics Inc (MCRB) is expected to report $-0.27 for 2Q.

Sotherly Hotels (SOHO) is expected to report for 2Q.

Sterling Check Corp (STER) is expected to report $0.10 for 2Q.

Theriva Biologics Inc (TOVX) is expected to report for 2Q.

UroGen Pharma Ltd (URGN) is expected to report $-0.84 for 2Q.

Venus Concept Inc (VERO) is expected to report $-1.59 for 2Q.

Vigil Neuroscience Inc (VIGL) is expected to report $-0.56 for 2Q.

XOMA Royalty Corp (XOMA) is expected to report $-0.26 for 2Q.

Xtant Medical Holdings Inc (XTNT) is expected to report $-0.02 for 2Q.

iTeos Therapeutics Inc (ITOS) is expected to report $-1.00 for 2Q.

Powered by Kantar Media and Dow Jones.


ANALYST RATINGS ACTIONS

Alcoa Raised to Buy From Sell by UBS

Allstate Raised to Equal-Weight From Underweight by Wells Fargo

Bank of Hawaii Cut to Underweight From Neutral by Piper Sandler

Blend Labs Raised to Buy From Hold by Canaccord Genuity

Brighthouse Financial Cut to Underweight From Equal-Weight by Wells Fargo

Brown & Brown Raised to Overweight From Equal-Weight by Wells Fargo

Camden Property Trust Raised to Buy From Underperform by B of A Securities

CBIZ Raised to Buy From Neutral by Sidoti & Co.

Churchill Downs Raised to Buy From Neutral by B of A Securities

Coherent Raised to Buy From Neutral by B of A Securities

Comstock Raised to Outperform From Market Perform by Noble Capital Markets

EchoStar Cut to Underweight From Neutral by JP Morgan

Eli Lilly Raised to Buy From Hold by Deutsche Bank

Gladstone Land Cut to Hold From Buy by Maxim Group

Goldman Sachs BDC Raised to Equal-Weight From Underweight by Wells Fargo

Hillenbrand Cut to Neutral From Buy by DA Davidson

IN8bio Cut to Hold From Buy by Jones Trading

Iteris Cut to Hold From Buy by Maxim Group

Janus International Group Cut to Peer Perform From Outperform by Wolfe Research

Mid-America Apartment Raised to Buy From Underperform by B of A Securities

Neuronetics Cut to Market Perform From Outperform by William Blair

Pacira BioSciences Cut to Sector Perform From Outperform by RBC Capital

Pacira BioSciences Cut to Underweight From Overweight by JP Morgan

Par Technology Raised to Buy From Hold by Jefferies

PennantPark Floatg Rt Cap Raised to Buy From Hold by Maxim Group

Pilgrim's Pride Cut to Market Perform From Outperform by BMO Capital

Power Integrations Raised to Outperform From Market Perform by Northland Capital Markets

Progressive Raised to Buy From Hold by HSBC

Prologis Cut to Neutral From Buy by B of A Securities

Prudential Financial Raised to Equal-Weight From Underweight by Wells Fargo

Qualcomm Cut to Peer Perform From Outperform by Wolfe Research

Revance Therapeutics Cut to Market Perform From Outperform by William Blair

Revance Therapeutics Cut to Neutral From Buy by Guggenheim

Robinhood Markets Raised to Overweight From Neutral by Piper Sandler

Sylvamo Cut to Neutral From Buy by B of A Securities

Take-Two Interactive Raised to Buy From Hold by HSBC

Taylor Morrison Home Raised to Outperform From Neutral by Zelman & Assoc

Triumph Group Cut to Hold From Buy by Jefferies

Zentalis Pharmaceuticals Raised to Neutral From Underperform by Wedbush

This article is a text version of a Wall Street Journal newsletter published earlier today.


(END) Dow Jones Newswires

08-13-24 0627ET